We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News   Feb 22, 2018 | Original Story from the Technical University of Denmark

 
Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

Credit: Boesen Photography & Design/boesenfoto.dk via DTU

 
 
 

RELATED ARTICLES

Epigenetic Signature May Help People Stay Ahead of IBD

News

In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.

READ MORE

Decoding the Structure of an RNA-Based CRISPR System

News

Over the past several years, CRISPR-Cas9 has moved beyond the lab bench and into the public zeitgeist. Now, scientists from the Salk Institute are reporting for the first time the detailed molecular structure of CRISPR-Cas13d, a promising enzyme for emerging RNA-editing technology.

READ MORE

Death and Decomposition Keeps the World Going

News

Scientists now have a better way to investigate how decomposing plants’ and animals’ contribute to the ecosystem.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE